RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers.
Single-cell functional genomics reveals determinants of sensitivity and resistance to natural killer cells in blood cancers.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
癌细胞对自然杀伤(NK)细胞介导的细胞毒性具有不同的敏感性,但其背后的决定因素尚不完全清楚。为系统解析这一问题,我们对多种癌细胞系进行了全基因组CRISPR筛选,并结合单细胞转录组读出,以研究NK细胞与癌细胞的相互作用。NK细胞与癌细胞的相互作用诱导了不同的激活状态和I型干扰素(IFN)反应,其模式取决于癌细胞谱系,从较敏感的髓系肿瘤到较不敏感的B淋巴细胞肿瘤不等。在癌细胞中进行的CRISPR筛选揭示了调控NK细胞介导杀伤敏感性和抵抗性的基因,包括黏附相关糖蛋白、蛋白聚糖、IFN基因以及转录调控因子,同时证实了抗原呈递和死亡受体信号通路的重要性。结合单细胞转录组读出的CRISPR筛选为潜在机制提供了深入见解,包括癌细胞中IFN-γ信号的调控以及NK细胞激活状态。我们的发现凸显了影响不同癌症中NK细胞敏感性的机制多样性,并为基于NK细胞的疗法提供了资源。
Cancer cells can evade natural killer (NK) cell activity, thereby limiting anti-tumor immunity. To reveal genetic determinants of susceptibility to NK cell activity, we examined interacting NK cells and blood cancer cells using single-cell and genome-scale functional genomics screens. Interaction of NK and cancer cells induced distinct activation and type I interferon (IFN) states in both cell types depending on the cancer cell lineage and molecular phenotype, ranging from more sensitive myeloid to less sensitive B-lymphoid cancers.
CRISPR screens in cancer cells uncovered genes regulating sensitivity and resistance to NK cell-mediated killing, including adhesion-related glycoproteins, protein fucosylation genes, and transcriptional regulators, in addition to confirming the importance of antigen presentation and death receptor signaling pathways. CRISPR screens with a single-cell transcriptomic readout provided insight into underlying mechanisms, including regulation of IFN-γ signaling in cancer cells and NK cell activation states.
Our findings highlight the diversity of mechanisms influencing NK cell susceptibility across different cancers and provide a resource for NK cell-based therapies.
MEMBER ACCOUNT
登录成功会直接打开下一页。